One tycoon's story of the cost of doing business in China.
Illustration by Tim Marrs
Editor's Note: Just after The Wire published this story, Desmond Shum said in an interview with NPR that Whitney Duan, his ex-wife who he had not heard from in four years, called to press him not to go ahead with publication of his book, Red Roulette. She had disappeared and had likely been arrested by the state on corruption charges. Their 12-year-old son had not heard from his mother in four years, until the call over the weekend. Desmond suspects she is still in detention but is being pressur
Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
A weekly curated reading list on China from Andrew Peaple.
A daily roundup of China finance, business and economics headlines.
We offer discounts for groups, institutions and students. Go to our Subscriptions page for details.
At the height of the pandemic, Chinese vaccine maker Sinovac was a hero and one of the country’s most promising companies. But its success masked a protracted dispute between rival investors and management for control of the cash-rich company. The Wire China investigates what went wrong.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OKPrivacy policy
